Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravenous Acetaminophen and Ketorolac for Pain Management During Extracorporeal Shockwave Lithotripsy: A Quasi-Randomized Controlled Trial

NCT07368738 is registered in ClinicalTrials.gov with Horizon Health Network as lead sponsor.

NCT NCT07368738
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07368738 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravenous Acetaminophen and Ketorolac for Pain Management During Extracorporeal Shockwave Lithotripsy: A Quasi-Randomized Controlled Trial
Lead sponsor
Horizon Health Network
Phase
Phase 4
Overall status
Enrolling by invitation
Start date
April 30, 2026
Completion date
April 30, 2027
Enrollment
266 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

extracorporeal shockwave lithotripsy